目的分析早发家族性阿尔茨海默病(early—onset familial Alzheimer’Sdisease,EO—FAD)患者血清特异性微小RNA(microRNA,miRNA)表达谱,为深入研究miRNA与EO-FAD发生发展的关系以及寻找EO—FAD分子标记物奠定基础。方法利用miRNA芯片就2例EO—FAD家系患者、2例EO—FAD家系携带者和2例正常对照者血清miRNA进行检测和初步信息学分析。结果miRNA芯片检测发现,与正常对照相比,EO—FAD患者血清中上调的miRNAs有21个,下调的有22条均差异有统计学意义(P〈0.05);其中miR-5704(P=0.0002)、miR-4639—3p(P=0.0195)和miR-107(P=0.0204)表达水平显著上调,miR-5572(P=0.0008)、miR-204—3p(P=0.0014)、miR-542—5p(P=0.0106)和miR-155—5p(P=0.0240)表达水平显著下调。KEGG生物通路分析表明表达水平上调或下调的miRNAs的靶基因可能通过影响参与EO—FAD的发病机制。结论miR-5704、miR-4639—3p、miR-107、miR-5572、miR-204—3p、miR-542—5p、miR-155—5p有可能成为EO—FAD的潜在分子标记物,并通过影响神经营养因子信号通路参与EO—FAD的发病机制。
Objective To determine the expression profile of serum microRNAs (miRNAs) in early- onset familial Alzheimer' s disease (EO-FAD) patients. Methods miRNA mieroarrays were performed to detect the expression profile of serum miRNAs in 2 cases of EO-FAD patients, 2 cases of EO-FAD carriers and 2 cases of normal controls.Preliminary bioinformatic analysis was conducted. Results It was found that 21 miRNAs were up-regulated and 22 miRNAs were down-regulated in serum of EO-FAD patients,the differ- ences were statistically significant (P〈0.05). miR-5704(P= 0.0002), miR-4639-3p(P= 0.0195 ), miR-107 (P= 0.0204) were markedly up-regulated, miR-5572 (P = 0.0008 ), miR-204-3p (P = 0.0014 ), miR-542-Sp (P = 0.0106 ) and miR- 155-5p (P= 0.0240) were markedly down-regulated. Kyoto Encyclopedia of Genes and Ge- nomes(KEGG) pathway analysis suggested that the dysregulated miRNAs may be involved in the mechanism of EO-FAD by affecting neurotrophin signaling pathway. Conclusion miR-5704, miR-4639-3p, miR-107, miR-5572,miR-204-3p, miR-542-Sp and miR-155-Sp may be used as potential biomarkers of EO-FAD, and involved in the mechanism of EO-FAD by affecting neurotrophin signaling pathway.